CFM
SGRY icon

Catalyst Funds Management’s Surgery Partners SGRY Stock Holding History

Catalyst Funds Management’s Portfolio SGRY Stock Details SGRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,600
Closed -$347K – 676
2025
Q1 		$347K Buy
+14,600
New +$346K 0.09% 245
2024
Q2 		– Sell
-300
Closed -$8.95K – 1556
2024
Q1 		$8.95K Buy
+300
New +$9.39K ﹤0.01% 902

Other funds holding SGRY

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
KSCM
King Street Capital Management New York $328M AUM 0.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Catalyst Funds Management's SGRY Position: Q2 2025 in Review

Catalyst Funds Management sold out of Surgery Partners (SGRY) in Q2 2025, closing a stake of 14,600 shares — an estimated $347K sold.

Catalyst Funds Management first reported a position in SGRY in Q1 2024 and held it in 2 quarters. The position peaked at $347K in Q1 2025. 201 funds tracked by Wall St. Rank hold SGRY as of Q2 2025.

  • Catalyst Funds Management reported no remaining Surgery Partners position as of Q2 2025 after selling out during the quarter.
  • Catalyst Funds Management sold 14,600 Surgery Partners shares in Q2 2025, an estimated $347K.
  • Catalyst Funds Management first reported a position in Surgery Partners in Q1 2024 and held it in 2 quarters.
  • Catalyst Funds Management's Surgery Partners position peaked at $347K in Q1 2025.
  • 201 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2025.

Based on Catalyst Funds Management's 13F filing for Q2 2025, filed 12 Aug 2025.